Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022018 bond Code: 113585 bond abbreviation: Shouxian convertible bond
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
Announcement on the general election of the board of directors
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) (hereinafter referred to as “the company”) the term of office of the third board of directors is about to expire. According to the company law, the securities law, the Listing Rules of Shanghai Stock Exchange and other laws and regulations, normative documents and the relevant provisions of the articles of association, the company shall conduct the general election of the board of directors in accordance with the procedures. The general election of the board of directors is hereby announced as follows:
The Fourth Board of directors of the company consists of nine directors, including three independent directors. The nomination committee of the third session of the board of directors carefully examined the qualification and performance ability of the candidates of the fourth session of the board of directors. The company held the 32nd meeting of the third session of the board of directors on March 31, 2022, considered and adopted the proposal on the election of non independent directors of the fourth session of the board of directors and the proposal on the election of non independent directors of the fourth session of the board of directors, Agree to nominate Mr. Li Mingyan, Mr. Li Zhenhao, Mr. Li Zhenyu, Ms. Liu Guofang, Mr. Huang Hangfeng and Mr. Xu Jing as candidates for non independent directors of the Fourth Board of directors of the company, and agree to nominate Mr. Han Haimin, Mr. Wang Ruwei and Mr. besai as candidates for independent directors of the fourth board of directors of the company (resume attached).
The independent directors of the third board of directors of the company issued unanimous independent opinions. Think:
1. The nomination and voting procedures of candidates for the board of directors of the company comply with the provisions of the articles of association and relevant laws and regulations, and are legal and effective;
2. This nomination is made on the basis of fully understanding the nominee’s educational background, work experience, part-time job, professional quality, etc. the nominee has high professional knowledge and rich practical work experience, has the qualification and ability to serve as a director and independent director of the company, and has not found any situation that he is not allowed to serve as a director specified in the company law and the articles of Association;
3. Agree to submit Mr. Li Mingyan, Mr. Li Zhenhao, Mr. Li Zhenyu, Ms. Liu Guofang, Mr. Huang Hangfeng and Mr. Xu Jing as candidates for non independent directors of the Fourth Board of directors to the general meeting of shareholders for deliberation; It is agreed that Mr. Han Haimin, Mr. Wang Ruwei and Mr. besai are candidates for independent directors of the Fourth Board of directors of the company and submitted to the general meeting of shareholders of the company for deliberation.
The above proposals need to be submitted to the 2021 annual general meeting of shareholders of the company for deliberation. The election of non independent directors and independent directors will be conducted in the form of cumulative voting system respectively. The directors of the Fourth Board of directors of the company will take office from the date of deliberation and approval by the general meeting of shareholders for a term of three years. The qualification of independent director candidates shall be filed with Shanghai Stock Exchange and submitted to the general meeting of shareholders for deliberation only after there is no objection.
Before the new board of directors is elected by the general meeting of shareholders, the third board of directors of the company will continue to perform its duties. It is hereby announced.
Annex: resume of candidates for the Fourth Board of directors
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors April 1, 2021
Annex: resume of candidates for the Fourth Board of directors
1. Resume of non independent director candidates
Mr. Li Mingyan, born in 1960, Chinese nationality, has no permanent right of residence abroad. He is currently the chairman and general manager of the company. He is also the executive director of Jinhua Qingyu Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) National Medicine Co., Ltd., the director of Hangzhou fanghuichuntang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) traditional Chinese medicine outpatient department Co., Ltd., the director of Hangzhou fanghuichuntang Pharmacy Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Museum Co., Ltd., the director of Zhejiang Wuyi Rural Commercial Bank Co., Ltd Supervisor of Zhejiang time honored brand new information technology Co., Ltd., executive director of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Investment Management Co., Ltd., executive director of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Tourism Co., Ltd., and executive director of Hejing County kekewusu Hydropower Development Co., Ltd.
Mr. Li Zhenhao, born in 1987, Chinese nationality, without permanent overseas residency, doctor of pharmacy of Zhejiang University, is currently the director of the company and the executive director and general manager of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Botanical Medicine Research Institute Co., Ltd.
Mr. Li Zhenyu, born in 1991, Chinese nationality, without permanent overseas residency, holds a master’s degree in international business and management from Birmingham City University, UK. He is now the assistant to the general manager of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Network Technology Co., Ltd., the executive director of Jinhua Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Pharmaceutical Co., Ltd., the executive director and general manager of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Jishi Health Development Co., Ltd Executive director of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) smart health development Co., Ltd., executive director and general manager of Hangzhou Haojing Network Technology Co., Ltd.
Ms. Liu Guofang, born in 1976, Chinese nationality, without permanent overseas residency, has a bachelor’s degree in law from Zhejiang University and a Chinese certified public accountant. He has successively served as a teacher of Yaoju primary school in Wangzhai Town, Wuyi County, deputy chief of the credit section of Chengguan City credit cooperative, Wuyi County, and assistant to the general manager of Jinhua Center branch of Tian’an Property Insurance Co., Ltd. He joined Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) , and is now a director, deputy general manager and Secretary of the board of directors of the company.
Mr. Huang Hangfeng, born in 1983, Chinese nationality, without permanent overseas residency, has a bachelor’s degree in food science and engineering from Zhejiang University of technology. He is now the general manager of Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) marketing center, the executive director of Zhejiang Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) health care management Co., Ltd., the supervisor of Hangzhou Panming Technology Co., Ltd., the executive director of Nanjing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd., the executive director of Shanghai Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd Supervisor of Hangzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd., general manager and executive director of Beijing Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd. and executive director of Suzhou Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Health Technology Co., Ltd.
Mr. Xu Jing, born in 1985, Chinese nationality, without permanent overseas residency, bachelor degree. Joined Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) , served as the chairman of the board of supervisors of the company in 2008, and now serves as the director and deputy general manager of the company.
2. Resume of independent director candidates
Han Haimin, male, born in 1973, with bachelor degree, senior accountant and certified tax agent, served as the chief of the tax management section of the first and second branches directly under Zhejiang Zhoushan Local Taxation Bureau from January 2004 to may 2013; From May 2013 to February 2015, he served as the deputy director (presiding over the work) of the investment promotion service division of the Management Committee of China (Zhoushan) bulk commodity trading center and the deputy director of the supervision and management division; At present, he is Servyou Software Group Co.Ltd(603171) researcher, senior tax consultant, expert tax lecturer and independent director of the company.
Wang Ruwei, male, born in December 1967, Chinese nationality, without permanent overseas residency. Doctor of medicine, professor level senior engineer and doctoral supervisor, national Shimane University, Japan. Member of the 10th and 11th National Pharmacopoeia Committee. He once served as vice president of the Sixth Affiliated Hospital of Wenzhou Medical University, vice chairman / President of Zhejiang Conba Pharmaceutical Co.Ltd(600572) company (A-share main board), vice chairman and President of Jiahe Jinyu Bio-Technology Co.Ltd(600201) Co., Ltd. (Hong Kong stock main board), and Hangzhou Tigermed Consulting Co.Ltd(300347) vice president (a + H). Now he is the managing director and independent director of Hangzhou Tailong venture capital partnership (limited partnership).
Besai, male, born in January 1984, Chinese nationality, without permanent overseas residency. Master of civil and commercial law, Southwest University of political science and law, second class lawyer. He is now the managing partner of Zhejiang zhhang law firm and the independent director of Zhejiang Zhaohui Filtration Technology Co., Ltd.
